Influence of Electronic Patient Reported Outcomes (ePROMs) in Surgical Therapy for Prostate Cancer on Postoperative Outcome
Launched by HEINRICH-HEINE UNIVERSITY, DUESSELDORF · Nov 30, 2022
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how using electronic Patient Reported Outcomes Measures (ePROMs) can help improve the recovery process for men undergoing surgery for prostate cancer. Specifically, the study aims to see if following patients closely with these electronic tools in the first year after their prostate surgery can help catch any postoperative symptoms early. The goal is to find out if this approach can lead to better management of issues like incontinence, overall symptom burden, quality of life, and how confident patients feel about their health.
To participate in this trial, men aged 18 and older who are planning to have their prostate removed due to cancer may be eligible. Participants need to be able to use a mobile device or computer, understand German, and complete electronic questionnaires, with help if needed. The trial is currently recruiting participants, and those who join can expect to use technology to report their health status regularly, which could help improve their recovery experience. It's important to note that those with severe health issues or pre-existing urinary incontinence may not qualify for this study.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • age ≥ 18 y
- • legal capacity
- • sufficient knowledge of the German language
- • prostate carcinoma, TNM T1-4 NX N0-1 M0-1c
- • primary radical prostatectomy planned
- • mobile input device or PC available
- • ability to either receive emails or install a special app on cell phone and receive push messages, with guidance or assistance if necessary
- • ability to complete electronic questionnaires, with guidance or assistance if necessary
- Exclusion Criteria:
- • palliative treatment situation (life expectancy \< 1 year)
- • preoperative urinary incontinence (at least one pad per 24 hours)
About Heinrich Heine University, Duesseldorf
Heinrich-Heine University Düsseldorf is a leading academic institution dedicated to advancing medical research and education. Renowned for its innovative approach to healthcare and interdisciplinary collaboration, the university plays a pivotal role in clinical trials aimed at improving patient outcomes and translating scientific discoveries into clinical practice. With a robust infrastructure and a commitment to ethical standards, Heinrich-Heine University fosters an environment that supports cutting-edge research initiatives, contributing significantly to the advancement of medical knowledge and therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bonn, North Rhine Westpahlia, Germany
Dortmund, North Rhine Westphalia, Germany
Düsseldorf, North Rhine Westphalia, Germany
Herne, North Rhine Westphalia, Germany
Münster, North Rhine Westphalia, Germany
Patients applied
Trial Officials
Peter Albers, MD
Principal Investigator
University Clinic Düsseldorf, Urology
André Karger, MD
Study Director
University Clinic Düsseldorf, psychosomatic medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials